Erlotinib vs Irbesartan

Erlotinib vs Irbesartan: Overview

This comparison examines the pharmacological differences between Erlotinib and Irbesartan.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Irbesartan — 11-15 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Irbesartan — C25H28N6O.

Molecular Weight: Erlotinib — 393.4380 g/mol; Irbesartan — 428.5320 g/mol.

Type: Erlotinib — Small molecule; Irbesartan — Small molecule.